The Evolving Market for Tissue Factor Pathway Inhibitors The Tissue Factor Pathway Inhibitors (TFPI) Market represents an innovative segment within the anticoagulant and hemostasis therapeutic domain. As a naturally occurring anticoagulant protein, TFPI regulates blood coagulation through inhibition of the tissue factor-factor VIIa complex, playing an essential role in hemostatic balance. Growing pharmaceutical research in coagulation disorders...
0 Shares
269 Views
0 Reviews